Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

Related Articles by Review for PubMed (Select 23273103)

1.

Racial disparities in the monitoring of patients on chronic opioid therapy.

Hausmann LR, Gao S, Lee ES, Kwoh CK.

Pain. 2013 Jan;154(1):46-52. doi: 10.1016/j.pain.2012.07.034.

PMID:
23273103
2.

Prescription opioid abuse in chronic pain: a review of opioid abuse predictors and strategies to curb opioid abuse.

Sehgal N, Manchikanti L, Smith HS.

Pain Physician. 2012 Jul;15(3 Suppl):ES67-92. Review.

3.

Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse.

McCarberg BH.

Postgrad Med. 2011 Nov;123(6):132-9. doi: 10.3810/pgm.2011.11.2503. Review.

PMID:
22104462
4.

A critical assessment of opioid treatment adherence using urine drug testing in chronic pain management.

McCarberg BH.

Postgrad Med. 2011 Nov;123(6):124-31. doi: 10.3810/pgm.2011.11.2502. Review.

PMID:
22104461
5.

Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain.

Starrels JL, Becker WC, Alford DP, Kapoor A, Williams AR, Turner BJ.

Ann Intern Med. 2010 Jun 1;152(11):712-20. doi: 10.7326/0003-4819-152-11-201006010-00004. Review.

PMID:
20513829
6.

Urine drug testing in chronic pain.

Christo PJ, Manchikanti L, Ruan X, Bottros M, Hansen H, Solanki DR, Jordan AE, Colson J.

Pain Physician. 2011 Mar-Apr;14(2):123-43. Review.

7.

Opioids, pain management and the law.

Stayner RS, Copenhaver DJ.

Curr Opin Anaesthesiol. 2012 Oct;25(5):566-71. doi: 10.1097/ACO.0b013e328357a24a. Review.

PMID:
22914352
8.

The pros and cons of long-term opioid therapy.

Duarte R, Raphael J.

J Pain Palliat Care Pharmacother. 2014 Sep;28(3):308-10. doi: 10.3109/15360288.2014.943383. Review.

PMID:
25166775
9.

What are we treating with chronic opioid therapy?

Krashin D, Sullivan M, Ballantyne J.

Curr Rheumatol Rep. 2013 Mar;15(3):311. doi: 10.1007/s11926-012-0311-1. Review.

PMID:
23371480
10.

Personalized medicine and opioid analgesic prescribing for chronic pain: opportunities and challenges.

Bruehl S, Apkarian AV, Ballantyne JC, Berger A, Borsook D, Chen WG, Farrar JT, Haythornthwaite JA, Horn SD, Iadarola MJ, Inturrisi CE, Lao L, Mackey S, Mao J, Sawczuk A, Uhl GR, Witter J, Woolf CJ, Zubieta JK, Lin Y.

J Pain. 2013 Feb;14(2):103-13. doi: 10.1016/j.jpain.2012.10.016. Review.

11.

Drug testing and adherence monitoring in pain management: Oral fluid testing.

Moore C.

J Opioid Manag. 2015 Jan-Feb;11(1):69-75. doi: 10.5055/jom.2015.0254. Review.

PMID:
25750167
12.

Urine drug testing of chronic pain patients. V. Prevalence of propoxyphene following its withdrawal from the United States market.

Puet B, DePriest A, Knight J, Heltsley R, Black DL, Caplan YH, Cone EJ.

J Anal Toxicol. 2013 Jan-Feb;37(1):1-4. doi: 10.1093/jat/bks083. Epub 2012 Nov 5. Review.

PMID:
23129731
13.

Demystifying analytical approaches for urine drug testing to evaluate medication adherence in chronic pain management.

McMillin GA, Slawson MH, Marin SJ, Johnson-Davis KL.

J Pain Palliat Care Pharmacother. 2013 Dec;27(4):322-39. doi: 10.3109/15360288.2013.847889. Epub 2013 Oct 22. Review.

PMID:
24147959
14.

Improving opioid prescription practices and reducing patient risk in the primary care setting.

Cheatle MD, Barker C.

J Pain Res. 2014 Jun 10;7:301-11. doi: 10.2147/JPR.S37306. eCollection 2014. Review.

15.

Can pragmatic trials help us better understand chronic pain and improve treatment?

Rowbotham MC, Gilron I, Glazer C, Rice AS, Smith BH, Stewart WF, Wasan AD.

Pain. 2013 May;154(5):643-6. doi: 10.1016/j.pain.2013.02.034. Epub 2013 Mar 7. Review. No abstract available.

PMID:
23541132
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk